Platelet and Coagulation System

The term "Platelet and Coagulation System" refers to two principal and interdependent elements of the body's hemostatic response. **Platelets** (thrombocytes) are cellular fragments that adhere to damaged blood vessels, aggregate, and form the initial "platelet plug"—the first step in halting bleeding[1][3]. The **coagulation system** describes the enzymatic cascade of clotting factors that results in the conversion of soluble fibrinogen into insoluble fibrin, stabilizing the platelet plug into a definitive blood clot[2][4][5]. The proper function and regulation of these systems are essential to prevent excessive bleeding (hemorrhagic conditions) or unwanted clotting (thrombotic disease). Disruption or dysregulation is implicated in disorders such as hemophilia, deep vein thrombosis, myocardial infarction, and stroke. Numerous drugs are available to modulate specific components of these systems, but there is no drug targeting the combined "Platelet and Coagulation System" as a single entity. **Key point:** This entry does **not** describe a specific molecule, gene, or receptor; it instead encompasses an entire network of cellular and protein components. For structured data, you should instead refer to individual molecular entities, such as "Glycoprotein IIb/IIIa", "Thrombin (Factor IIa)", or "Von Willebrand factor", etc.[1][2][5]

Other names

Platelet systemCoagulation cascadeHemostatic system